On a mission to cure FTD

The Progranulin Information Navigator was created by the Bluefield Project to Cure FTD as part of its mission to accelerate the development of treatments for FTD caused by progranulin gene (GRN) variants.  Bluefield funds research to better understand why GRN variants cause FTD and potential approaches to treatment. With a growing number of clinical trials for FTD, Bluefield has expanded its focus to help improve access to information about clinical trials, genetic counseling and testing.

What is the Bluefield Project?

The Bluefield Project is a 501(c)(3) non-profit research foundation dedicated to accelerating the development of treatments for FTD. Founded in 2010, the Bluefield Project funds academic research and collaborative initiatives to understand the underlying mechanisms of disease and advance therapeutic opportunities.

The team behind the
Progranulin Information Navigator

The team behind the Progranulin Information Navigator

LAURA MITIC, PhD

Acting President & Chief Scientific Officer

Learn MoreLearn More

ALEXANDRA (ANDRA) NICHOLSON, PhD

Director, Research Partnerships

Learn MoreLearn More

RACHEL ACUNA-NARVAEZ, JD

Project Manager, Biomarker Operations

Learn MoreLearn More

ERYNN GORDON, MS, CGC

Program Manager, Progranulin Information Navigator

Learn MoreLearn More

Learn more about the Bluefield Project

Learn More